These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 37639911)
1. Effect of the MiR-99b and MiR-135b on peritoneal carcinomatosis and liver metastasis in colorectal cancer. Aziret M; Güney Eskiler G; Çakar GÇ; Özkan AD; Ercan M; Bilir C; Polat E; Koçer HB; Yıldırım EK; Duman M Clinics (Sao Paulo); 2023; 78():100271. PubMed ID: 37639911 [TBL] [Abstract][Full Text] [Related]
2. miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR. Li W; Chang J; Wang S; Liu X; Peng J; Huang D; Sun M; Chen Z; Zhang W; Guo W; Li J Oncotarget; 2015 Sep; 6(27):24448-62. PubMed ID: 26259252 [TBL] [Abstract][Full Text] [Related]
3. miR-182 and miR-135b Mediate the Tumorigenesis and Invasiveness of Colorectal Cancer Cells via Targeting ST6GALNAC2 and PI3K/AKT Pathway. Jia L; Luo S; Ren X; Li Y; Hu J; Liu B; Zhao L; Shan Y; Zhou H Dig Dis Sci; 2017 Dec; 62(12):3447-3459. PubMed ID: 29030743 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway. Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179 [TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway. Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655 [TBL] [Abstract][Full Text] [Related]
6. MicroRNAs associated with initiation and progression of colonic polyp: a feasibility study. Aslam MI; Hussein S; West K; Singh B; Jameson JS; Pringle JH Int J Surg; 2015 Jan; 13():272-279. PubMed ID: 25496852 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-135b regulates metastasis suppressor 1 expression and promotes migration and invasion in colorectal cancer. Wu W; Wang Z; Yang P; Yang J; Liang J; Chen Y; Wang H; Wei G; Ye S; Zhou Y Mol Cell Biochem; 2014 Mar; 388(1-2):249-59. PubMed ID: 24343340 [TBL] [Abstract][Full Text] [Related]
8. Relationship between Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580 [TBL] [Abstract][Full Text] [Related]
9. Mutant KRAS promotes liver metastasis of colorectal cancer, in part, by upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling pathway. Chu PC; Lin PC; Wu HY; Lin KT; Wu C; Bekaii-Saab T; Lin YJ; Lee CT; Lee JC; Chen CS Oncogene; 2018 Jun; 37(25):3440-3455. PubMed ID: 29559746 [TBL] [Abstract][Full Text] [Related]
10. Exosomal miR-99b-5p Secreted from Mesenchymal Stem Cells Can Retard the Progression of Colorectal Cancer by Targeting FGFR3. Ning S; Chen Y; Li S; Liu M; Liu H; Ye M; Wang C; Pan J; Wei W; Li J; Zhang L Stem Cell Rev Rep; 2023 Nov; 19(8):2901-2917. PubMed ID: 37653181 [TBL] [Abstract][Full Text] [Related]
11. Identification of high-risk Dukes B colorectal cancer by microRNA expression profiling: a preliminary study. Aslam MI; Venkatesh J; Jameson JS; West K; Pringle JH; Singh B Colorectal Dis; 2015 Jul; 17(7):578-88. PubMed ID: 25557290 [TBL] [Abstract][Full Text] [Related]
12. KRAS status in patients with colorectal cancer peritoneal carcinomatosis and its impact on outcome. Gillern SM; Chua TC; Stojadinovic A; Esquivel J Am J Clin Oncol; 2010 Oct; 33(5):456-60. PubMed ID: 19952717 [TBL] [Abstract][Full Text] [Related]
13. Identification of stool miR-135b-5p as a non-invasive diaognostic biomarker in later tumor stage of colorectal cancer. Li L; Wang A; Cai M; Tong M; Chen F; Huang L Life Sci; 2020 Nov; 260():118417. PubMed ID: 32931801 [TBL] [Abstract][Full Text] [Related]
14. Differential microRNA expression profiling in primary tumors and matched liver metastasis of patients with colorectal cancer. Li W; Chang J; Tong D; Peng J; Huang D; Guo W; Zhang W; Li J Oncotarget; 2017 May; 8(22):35783-35791. PubMed ID: 28415758 [TBL] [Abstract][Full Text] [Related]
15. Identification of microRNA-487b as a negative regulator of liver metastasis by regulation of KRAS in colorectal cancer. Hata T; Mokutani Y; Takahashi H; Inoue A; Munakata K; Nagata K; Haraguchi N; Nishimura J; Hata T; Matsuda C; Murata K; Mizushima T; Doki Y; Mori M; Yamamoto H Int J Oncol; 2017 Feb; 50(2):487-496. PubMed ID: 28000854 [TBL] [Abstract][Full Text] [Related]
16. miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer. Li J; Liang H; Bai M; Ning T; Wang C; Fan Q; Wang Y; Fu Z; Wang N; Liu R; Zen K; Zhang CY; Chen X; Ba Y PLoS One; 2015; 10(6):e0130194. PubMed ID: 26061281 [TBL] [Abstract][Full Text] [Related]
18. Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer. Hur K; Toiyama Y; Okugawa Y; Ide S; Imaoka H; Boland CR; Goel A Gut; 2017 Apr; 66(4):654-665. PubMed ID: 26701878 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway. Li YJ; Wang Y; Wang YY J Cell Physiol; 2019 Jun; 234(6):9577-9591. PubMed ID: 30480801 [TBL] [Abstract][Full Text] [Related]